Crossmark

A response of rituximab plus lenalidomide therapy in patients with post-transplant lymphoproliferative disease and methotrexate-related lymphoproliferative disorder in the central nervous system: a case report

Crossref DOI link: https://doi.org/10.1186/s13256-025-05307-x

Published Online: 2025-05-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Guo, Hanguo

Zhang, Hong

Li, Wenyu
License Information

Text and Data Mining valid from 2025-05-21

Version of Record valid from 2025-05-21
More Information

Article History

Received: 1 November 2024

Accepted: 4 April 2025

First Online: 21 May 2025

Declarations

:

: The use of these cases was approved by the Ethics Committee of Guangdong Provincial People’s Hospital, and written informed consent was obtained from the patients for the publication of their cases, including radiographic and pathological images. The ethics approval number was KY2025-100-01.

: Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

: The authors of this manuscript have no conflicts of interest.

Document is current

Any future updates will be listed below